↑(en) Berlin I, Zimmer R, Thiede HM, et al., « Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects », British journal of clinical pharmacology, vol. 30, no 6, , p. 805–16 (PMID1705137, PMCID1368300)